The Radiologist's Role in Improving DBT Access Equity

Video

Radiologists may not order a DBT exam for African American patients, but they can participate in improving access to the screening.

African American women have significantly less access to digital breast tomosynthesis (DBT) that do their white counterparts, according a study published recently in the Journal of the American College of Radiology.

Even though DBT improves cancer detection and reduces recall rates, researchers from PennMedicine found that, based on their study population of more than 385,000 women, only 44 percent of African American women undergo DBT. Among Asian and white women, the rates of 63 percent and 61 percent, respectively.

This inequity in access presents a significant problem because African American women are more likely to be diagnosed with more aggressive forms of breast cancer at younger ages. Having easier, more consistent access to could greatly improve their outcomes.

Although radiologists and mammographers do not order DBT exams for these women, they do have a role to play in improve access and reducing the inequity, said Linda Blount, MPH, president and chief executive officer for Black Women’s Health Imperative, a non-profit organization dedicated to improving health and wellbeing for African American women and girls.

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.